Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug delivery systems for hormone therapy.

Jin-Wook Yoo1, Chi H Lee

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Missouri, Kansas City, MO 64110, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|March 15, 2006
PubMed
Summary

Hormone therapy (HT) remains crucial for menopausal symptoms and osteoporosis despite past controversies. Optimizing current estrogen and progestogen formulations is key to improving patient compliance and reducing side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXCL6 exacerbates metabolic dysfunction-associated steatohepatitis by suppressing LPIN1-mediated fatty acid oxidation in hepatocytes.

International journal of biological sciences·2026
Same author

Local drug delivery for oral squamous cell carcinoma under oral cavity.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

Polydopamine-mediated multi-stage delivery for precise local therapy of Helicobacter pylori-infected gastric ulcers.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials (2020-2025).

Inflammopharmacology·2026
Same author

Once and thrice weekly interval training in adults with central obesity: a randomized controlled trial.

Nature communications·2026
Same author

Carbutamide, an Obsolete Anti-Diabetic Drug, Has Potential as a Potent Anticolitic Agent via Azo-Conjugation with Mesalazine.

Pharmaceutics·2025

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Hormone therapy (HT) is a primary treatment for menopausal symptoms and osteoporosis.
  • The Women's Health Initiative (WHI) study yielded controversial findings regarding estrogen/progestin combination therapy.
  • Novel HT alternatives are unlikely to be available clinically within the next decade.

Purpose of the Study:

  • To review and compare various hormone therapy formulations and delivery devices.
  • To evaluate the modes of hormone action and patient responses to different HT types.
  • To guide the optimization of existing HT formulations for improved clinical outcomes.

Main Methods:

  • Extensive literature review and comparative analysis of existing HT formulations.

Related Experiment Videos

  • Evaluation of hormone action mechanisms across different delivery systems.
  • Assessment of patient responses and adverse effects associated with various HT options.

    • Main Results:

    • Diverse HT formulations and delivery devices exist, with varied efficacy and safety profiles.
    • Patient responses to HT are influenced by formulation type, delivery method, and individual factors.
    • Optimization of current estrogen and progestogen formulations is feasible and necessary.

    Conclusions:

    • Current hormone therapy formulations require optimization to maximize patient compliance and minimize adverse effects.
    • Comparative analysis of HT characteristics can inform the development of more efficient delivery systems.
    • Improving existing HT options is essential given the lack of imminent novel therapeutic alternatives.